Fairmont Chateau Whistler, Whistler, British Columbia
Words of Welcome
We are excited to invite you to attend the Canadian Breast Cancer Symposium at Whistler, BC January 31 and February 1, 2020. As in previous years the Symposium’s objective is to provide state of the art information to optimally manage our breast cancer patients. Another focus for this Canadian meeting is to increase communication and collaboration among breast cancer treaters nationwide.
The symposium will focus on molecular biology of breast cancer especially its clinical application as we move into personalized therapy for our patients. As in our clinics a multi-disciplinary approach to management of different presentations of breast cancer will be pursued through our panel discussions and case presentations. Thus, this symposium is designed to provide a comprehensive and real life review of the many facets of breast cancer.
There will be opportunity for audience participation via keypad polling devices with the faculty featured during the panel discussions. This smaller and more intimate meeting allows for much networking with the speakers and your colleagues. We aim to bring a Canadian perspective to the management of breast cancer patients and look forward to your input as to ways in which we can work together to optimize the care of our patients.
We look forward to your participation in this exciting symposium which promises to be a valuable educational experience.
Wendy Lam, B Sc (Pharm), MD, FRCPC
Burnaby Hospital Regional Cancer Centre,
Burnaby, British Columbia
On behalf of the Planning Committee:
Vanessa Bernstein, MD, FRCPC, University of British Columbia, Victoria
Christine Brezden-Masley, MD, PhD, FRCPC, University of Toronto, Toronto
Stephen Chia, MD, FRCPC – University of British Columbia, Vancouver
Debjani Grenier, BSc., MD, FRCPC, University of Manitoba, Winnipeg
Anil Abraham Joy, BSc., MD, FRCPC, University of Alberta, Edmonton
Josée-Anne Roy, MD,FRCPC, University of Laval, Quebec City
Christine Simmons, MD, MSc., FRCPC, University of British Columbia, Vancouver
Dr. Sunil Verma, MD, MSEd., FRCPC, University of Calgary, Alberta
At the completion of the meeting, attendees should be able:
- To appreciate molecular biology of breast cancer and its clinical application
- To discuss new approaches in radiation and surgical management of breast cancer
- To review important endpoints in breast cancer research
- To highlight emerging data presented at recent national and international breast cancer symposiums
- To apply the existing data to daily decision making and management of patients with breast cancer
This meeting is directed toward medical, radiation and surgical oncologists, general practitioners in oncology, oncology fellows, nurses, pharmacists and allied health professionals interested in treatment of breast cancer.